Clinical Trial

Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes

Study acronym: T3cDM-AKT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 6, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to better understand how the pancreas works in adults with type 2 diabetes. The study focuses on both hormone production (endocrine function) and digestive function (exocrine function) of the pancreas. The main questions it aims to answer are: * Can problems with the pancreas help identify a different type of diabetes called pancreatogenic diabetes? * How are blood markers and pancreas structure related to pancreatic function? Participants will: * Have blood tests to measure glucose, insulin, and other markers * Provide a stool sample to assess digestive function * Undergo an ultrasound examination of the pancreas * Answer questions about digestive symptoms The study will take place during a single visit in outpatient clinics.
Trial Details
NCT Number NCT07512934
Lead Sponsor West Kazakhstan Marat Ospanov Medical University
Collaborators: Universitatea de Stat de Medicina si Farmacie Nicolae Testemiţanu
Conditions Pancreatogenic Diabetes Mellitus, Type 2 Diabetes Mellitus (T2DM), Exocrine Pancreatic Insufficiency (EPI)
Enrollment 310 participants
Start Date 2025-07-07
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-06